Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1405-1412
Published online before print April 13, 2006, doi: 10.1161/01.ATV.0000222011.13026.25
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/6/1405    most recent
01.ATV.0000222011.13026.25v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kathiresan, S.
Right arrow Articles by O’Donnell, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kathiresan, S.
Right arrow Articles by O’Donnell, C. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Fibrinogen/fibrin
Right arrow Coagulation and fibronolysis
Right arrow Thrombosis risk factors
Right arrow Genomics
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1405.)
© 2006 American Heart Association, Inc.


Thrombosis

Common Genetic Variation in Five Thrombosis Genes and Relations to Plasma Hemostatic Protein Level and Cardiovascular Disease Risk

Sekar Kathiresan; Qiong Yang; Martin G. Larson; Amy L. Camargo; Geoffrey H. Tofler; Joel N. Hirschhorn; Stacey B. Gabriel; Christopher J. O’Donnell

From the National Heart, Lung, and Blood Institute Framingham Heart Study (S.K., Q.Y., M.G.L., C.J.O.), Framingham, Mass; Broad Institute of Harvard University and Massachusetts Institute of Technology (S.K., S.B.G., A.L.C., J.N.H., C.J.O.), Cambridge; Department of Biostatistics (Q.Y.), Boston University School of Public Health, Department of Neurology (Q.Y.), Boston University School of Medicine, Department of Mathematics and Statistics (M.G.L.), Boston University, Massachusetts; Royal North Shore Hospital (G.H.T.), Sydney, Australia; Divisions of Genetics and Endocrinology (J.N.H.), Children’s Hospital and Department of Genetics, Harvard Medical School, Boston, Mass; and Cardiology Division (S.K., C.J.O.), Massachusetts General Hospital, Harvard Medical School, Boston.

Correspondence to Christopher J. O’Donnell, MD, MPH, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702-5827. E-mail odonnellc{at}nhlbi.nih.gov

Objective— We undertook a linkage disequilibrium (LD)–based genetic approach to investigate the hypothesis that common sequence variants in 5 thrombosis genes influence plasma hemostatic protein levels or risk of cardiovascular disease (CVD).

Methods and Results— In a reference panel, we characterized LD structure at the fibrinogen gene cluster (fibrinogen-ß[FGB], FGA, and FGG), factor VII (F7), and tissue plasminogen activator (PLAT) loci. Forty-one tag single nucleotide polymorphisms (SNPs) were genotyped in 1811 unrelated Framingham Heart Study participants. There were significant associations of 9 FGB SNPs with fibrinogen level (minimum P=0.002) and of 7 F7 SNPs and factor VII level (minimum P<0.0001). SNPs at the PLAT locus were not associated with PLAT level. In stepwise analysis, a single FGB variant explained 1% of the residual variance in fibrinogen level, and 2 F7 SNPs together explained 10% of the residual variance in factor VII level. Two PLAT haplotypes were associated with CVD (multivariable-adjusted global P=0.0004).

Conclusions— A comprehensive survey of common sequence variation demonstrates that cis-regulatory SNPs explain a modest proportion of the residual variance in circulating fibrinogen and factor VII level and PLAT haplotypes increase the risk of CVD. Additional studies are warranted to confirm the association of PLAT sequence variation and risk of CVD.

We hypothesized that cis-acting SNPs influence hemostatic protein levels or CVD risk. In Framingham Heart Study participants, a single FGB SNP explained 1% of fibrinogen level variance, and 2 F7 SNPs together explained 10% of F7 level variance. PLAT gene haplotypes were associated with CVD.


Key Words: coagulation • fibrinogen • genetics • myocardial infarction • plasminogen activators • thrombosis • polymorphism




This article has been cited by other articles:


Home page
BloodHome page
V. J. Christiansen, K. W. Jackson, K. N. Lee, and P. A. McKee
The effect of a single nucleotide polymorphism on human {alpha}2-antiplasmin activity
Blood, June 15, 2007; 109(12): 5286 - 5292.
[Abstract] [Full Text] [PDF]